The Significance of the MMRF featuring Sagar Lonial, MD

Why Winship? - Sagar Lonial, MDПодробнее

Sagar Lonial, MD on elotuzumab for mutliple myeloma patientsПодробнее

Sagar Lonial discusses his top myeloma research picksПодробнее

Health Policy, Sagar Lonial, MD - Medpage TodayПодробнее

Dr. Sagar Lonial on Understanding Multiple MyelomaПодробнее

Sagar Lonial, MD, FACP, on Multiple Myeloma Awareness MonthПодробнее

Sagar Lonial, MD, FACP, Talks Multiple Myeloma Highlights from the Summer ConferencesПодробнее

Myeloma Crowd Radio: Sagar Lonial, MD, Winship Cancer InstituteПодробнее

IMS Highlights for Triple Class Refractory Myeloma | Sagar Lonial, MD, FACP | IMS 2023Подробнее

Dr. Sagar Lonial Talks On the Value of Attending Winter HemaologyПодробнее

Dr Sagar Lonial Discusses Data from ASCO and EHA 2019 in Transplant eligible patientsПодробнее

ASH Impact Series: Sagar Lonial, MD - Treating Newly Diagnosed Multiple MyelomaПодробнее

COMy 2016 Monoclonal Antibodies - Treatment of MM: LonialПодробнее

Sagar Lonial Introduces Blood Cancers TodayПодробнее

Dr. Lonial Discusses the Importance of Partnering With a Myeloma CenterПодробнее

Sagar Lonial MD, FACP tells us about the immunomodulatory mechanism of action of daratumumabПодробнее

Final analysis of the DREAMM-2 trial: belantamab mafodotin for R/R multiple myelomaПодробнее

ASH Impact Series: Sagar Lonial, MD - Examining Multiple Myeloma Drug Combination TreatmentsПодробнее